drugset / Trial / NCT00385840

Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate

NCT00385840

Phase 2 Completed 678 enrolled GlaxoSmithKline
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to evaluate the immunogenicity and the safety of a second vaccination with candidate vaccine compared to Fluarix™ administered intramuscularly in elderly aged 60 years and above

Timeline

Start
2006-10-20
Primary completion
2007-02-01
Completion
2007-02-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator FluarixTM Vaccine Intramuscular
Subject GSK1247446A Vaccine Intramuscular

Indications